InsidersTradesSigma
Follow the 레메디 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). The latest transaction was reported on 16 July 2026 (Purchase). Among the most active insiders: 조봉호. All data is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
레메디 是一家在XKRX市场上市的公司。它专注于健康和生物技术领域。